With the analysis among 381 patents, we discovered top 81 key players by total patent application. Gilead Sciences, Inc., Zambon Group SpA, Cardeas Pharma Corp. are dominant in this area. They take 23.36% of the total patent filing.
California, United States
Patent: 42
Washington, United States
Patent: 23
Texas, United States
Patent: 15
Tokyo-to, Japan
Patent: 13
Hessen, Germany
Patent: 12
Hubei Sheng, China
Patent: 12
Liaoning Sheng, China
Patent: 10
With the analysis among 6 patents, we discovered top 1 start-ups by total patent application.
California, United States
Patent: 6
With the analysis among related 84 patents applied in the last 5 years. We discover 36 most active companies in this area. The fast-growing HKUST Huacai (Wuhan) Biotechnology Co., Ltd., Nabriva Therapeutics Ireland DAC, Zavante Therapeutics, Inc. take 29.76% of patent filing during this period.
Hubei Sheng, China
Patent: 12
California, United States
Patent: 6
Hubei Sheng, China
Patent: 4
Missouri, United States
Patent: 2
With the analysis among related 84 patents in last 5 years, we discover 30 new entrants. HKUST Huacai (Wuhan) Biotechnology Co., Ltd., Nabriva Therapeutics Ireland DAC, Zavante Therapeutics, Inc. are the most active new entrants in this area.
Hubei Sheng, China
Patent: 12
California, United States
Patent: 6
Missouri, United States
Patent: 2
Missouri, United States
Patent: 2
Shanghai Shi, China
Patent: 2
With the analysis among 53 patents, we discovered top 22 universities and scientific research institutions by total patent application. Guangxi University, Wuhan Institute of Technology, Washington University in St. Louis are dominant in this area. They take 33.96% of the total patent filing.
Guangxi Zhuangzu Zizhiqu, China
Patent: 8
Hubei Sheng, China
Patent: 5
Missouri, United States
Patent: 2
Virginia, United States
Patent: 2
Missouri, United States
Patent: 2
District of Columbia, United States
Patent: 2
Aichi-ken, Japan
Patent: 1
Beijing Shi, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Shaanxi Sheng, China
Patent: 1